Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-01-07

Clinical Trial Update: IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing intravenous iron sucrose versus oral ferrous sulfate for iron deficiency anemia in children with inflammatory bowel disease was withdr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ferrous sulfate (ferrous sulfate)
  • Iron sucrose (iron sucrose)

Snippet

Sponsor: Wayne State University | Conditions: Iron Deficiency Anemia, Inflammatory Bowel Disease | Phase 2 | Status: WITHDRAWN